Medicinova (MNOV) Assets Average (2011 - 2025)
Medicinova's (MNOV) quarterly Assets Average came in at $46.6 million in Q4 2025, down 18.26% year-on-year from $57.0 million in Q4 2024, and down 4.33% on a QoQ basis from $48.7 million in Q3 2025.
Medicinova (MNOV) Assets Average (2011 - 2025) Analysis & Trends
Medicinova (MNOV) has 15 years of Assets Average data on file, last reported at $46.6 million in Q4 2025.
- On a quarterly basis, Assets Average fell 18.26% year-over-year to $46.6 million in Q4 2025; TTM through Dec 2025 was $46.6 million, a 18.26% decrease from a year earlier, with the FY2025 full-year figure at $50.7 million, down 16.92% from the prior year.
- Assets Average for Q4 2025 stood at $46.6 million, down from $48.7 million in the prior quarter.
- Over the last five years, Assets Average for MNOV reached as high as $94.9 million in Q2 2021 and fell as low as $46.6 million in Q4 2025.
- Historically, Assets Average has averaged $70.4 million across 5 years, with a median of $69.2 million in 2023.
- Across the five-year window, Assets Average increased 24.16% in 2021 and decreased 18.26% in 2025, its largest moves.
- Year by year, Assets Average stood at $89.5 million in 2021, then retreated by 14.79% to $76.3 million in 2022, then decreased by 11.89% to $67.2 million in 2023, then fell by 15.19% to $57.0 million in 2024, then dropped by 18.26% to $46.6 million in 2025.
- Per Business Quant data, the three most recent Assets Average figures were $46.6 million in Q4 2025, $48.7 million in Q3 2025, and $51.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 46.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.59 Mn |
| Sep 30, 2025 | 48.70 Mn |
| Jun 30, 2025 | 51.13 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 57.00 Mn |
| Sep 30, 2024 | 59.26 Mn |
| Jun 30, 2024 | 61.65 Mn |
| Mar 31, 2024 | 64.58 Mn |
| Dec 31, 2023 | 67.20 Mn |
| Sep 30, 2023 | 68.43 Mn |
| Jun 30, 2023 | 69.93 Mn |
| Mar 31, 2023 | 72.64 Mn |
| Dec 31, 2022 | 76.27 Mn |
| Sep 30, 2022 | 79.81 Mn |
| Jun 30, 2022 | 82.71 Mn |
| Mar 31, 2022 | 85.79 Mn |
| Dec 31, 2021 | 89.52 Mn |
| Sep 30, 2021 | 92.65 Mn |
| Jun 30, 2021 | 94.89 Mn |
| Mar 31, 2021 | 85.76 Mn |